ArticleSystematic reviews2026
Reviewing ecosystems of evidence: synthesising the evidence on the commercial determinants of health from a complex systems perspective.
Article in Systematic reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- 'Putting profit over people': Australian women's perceptions of the economic and commercial systems shaping women's health and social inequities.Health promotion international · 2026Article
- Political prioritization of alcohol and sugar-sweetened beverage taxation in Uganda: Agenda dynamics amidst a shifting funding landscape.Globalization and health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Commercial Determinants of Health (CDoH) are the systems, practices, and pathways through which commercial actors drive health and equity. This includes their influence on systems of evidence production and dissemination (evidence ecosystems) in order to protect and promote commercial interests. In the Commercial Determinants of Health and Evidence Synthesis (CODES) methodological guidance, we provided advice for conducing CDoH relevant evidence syntheses, from developing a protocol to reporting the review and planning an update. This follow-up paper considers reasons and practical implications for integrating a complex systems perspective in such reviews. This commentary describes how a complex systems perspective can benefit research, including evidence synthesis related to the CDoH, by embracing the complexity of the real world, understanding interventions in context, rendering visible the corporate playbook, and exposing the power dynamics that drive inequity. We then reflect on the practical implications of adopting a complex systems approach in CDoH evidence synthesis, including drawing on a systems lens and/or incorporating specific systems methods in the review. This commentary complements existing CODES guidance in highlighting considerations for conducting CDoH relevant evidence synthesis from a complex systems perspective. It can help interpreting such reviews and raise awareness of how commercial actors can shape evidence ecosystems, particularly evidence synthesis. Having a robust evidence base that considers systems elements and dynamics will support effective action to address the CDoH, improve public health and reduce inequity at scale.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.